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information on hepatitis C and other bloodborne viruses is
also needed in non-healthcare settings, particularly in prac-
tices where sharp instruments such as slicers that are likely
to cause hand injuries are used and shared by workers. In
these practices, healthcare authorities should highlight the
importance of wearing gloves and the prevention of cutting
injuries.
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Abstract
The detection of emerging infectious diseases has been a contin-
uing concern, especially with the novel inﬂuenza A (H1N1) viral
pandemic of 2009. In the present study, we validated a ‘second-
generation’ parallel sequencing platform for viral detection in
swab samples collected during recent inﬂuenza virus infections
in Beijing. This operation yielded millions of valid reads per sam-
ple and resulted in an almost complete spectrum of nucleotide
information. Importantly, novel A (H1N1) and seasonal A
(H3N2) inﬂuenza virus-derived sequences were detected with-
out prior knowledge or use of genetic information in advance,
suggesting that this approach could be a valuable tool for diag-
nosing emerging infectious diseases.
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The detection of emerging infectious diseases, such as severe
acute respiratory syndrome, highly pathogenic avian inﬂuenza
H5N1 and novel inﬂuenza A (H1N1), has become a continu-
ous public health concern. Thus, the accurate diagnosis of
pathogens in samples is becoming increasingly important.
Currently, nucleic acid ampliﬁcation tests (NAATs), such as
PCR, nucleic acid sequence-based ampliﬁcation, loop-medi-
ated isothermal ampliﬁcation and DNA microarray, are used
with greater frequency in preference to traditional culture-
or antigen-based diagnostic procedures, primarily as a result
of their greater sensitivity. However, almost all diagnostic
NAATs require viral genome information in advance, and
thus cannot be used to detect or characterize novel or
unexpected viral infections. Likewise, these methods are
completely ineffective if a viral genome has evolved sufﬁ-
ciently to result in point mutations at primer binding sites
[1,2].
New sequencing technologies referred to as ‘second-gen-
eration,’ such as 454 (Roche, Mannheim, Germany), Solexa
(Illumina, Inc., San Diego, CA, USA) and SOLiD (Applied
Biosystems, Foster City, CA, USA), show promise for the
unbiased detection of pathogens. These systems allow
researchers to obtain millions of sequences in a single round
of operation, as well as an almost complete spectrum of
nucleotide information through comparison and analysis with
relevant databases. Because the 454 system has previously
identiﬁed viral pathogens in nasal and faecal specimens [3],
we tested the ability of Solexa, another unbiased high-
throughput sequencing platform, to detect viral infections in
clinical specimens without using any viral genetic information
in advance.
In the present study, four patient swab samples were
obtained during novel inﬂuenza A (H1N1) outbreaks (sam-
ples 1, 2 and 3) and seasonal inﬂuenza virus A (H3N2) infec-
tions (sample 4) in May 2009 from the Laboratory of Beijing
CDC, China. One swab sample from a healthy individual
(sample 5) was used as a negative control.
Total RNA was isolated from each sample using the QIA-
amp RNeasy minikit (Qiagen, Hildenberg, Germany). cDNA
was synthesized using the M-MLV RTase cDNA synthesis kit
(Takara Bio Inc., Otsu, Japan), and fragmented by nebulizers
(Illumina, Inc.) to <800 bp. The overhangs resulting from
fragmentation were converted into blunt ends using T4
DNA polymerase and Escherichia coli polymerase I Klenow
fragment. After an ‘A’ base was added to the 3¢ end, the
adapters were ligated to the ends of the DNA fragments.
Unligated adapters were then removed, after which the
genomic DNA library was obtained by PCR (primer F: 5¢-
AATGATACGGCGACCACCGAGATCTACACTCTTTCCC
TACACGACGCTCTTCCGATCT-3¢; primer R: 5¢-CAAGCA
GAAGACGGCATACGAGCTCTTCCGATCT-3¢). Sequenc-
ing and sequence analysis were performed using the SBS
sequencing kit v3 and the Genome Analyzer, respectively
(Illumina, Inc.).
The quality of the sequencing reads from each sample was
ensured by the parallel sequencing of in-house samples, and
also included the removal of reads with unrecognized sites
or sequencing adaptors, and duplicate reads. Valid reads
were screened for host contaminants against the human ref-
erence genome using ELAND software, a part of the Solexa
analysis pipeline [Cox AJ, unpublished data]. The remaining
reads were searched among the microbes subset (viruses,
bacteria, fungi and protozoa) of the RefSeq database [4] for
taxonomy classiﬁcation using MAQ software [5].
A summary of the sequencing data obtained using the
Solexa system is shown in Fig. 1. The relative ratio of reads
matched with the RefSeq database to the total valid reads
was 5–17% for each sample. As expected, the ratio of
reads matched with human mRNA was in the range 39––
56% because total RNA, and not just pathogenic RNA, was
isolated from the swab samples. The other 19–44% reads
matched with neither host mRNA, nor the RefSeq data-
base, most likely because the RefSeq database mainly
focuses on representative strains of taxonomically estab-
lished organisms.
Sequences corresponding to hundreds of microbes in the
swab samples were characterized directly from the sequenc-
ing reads matched with the RefSeq database. The fully-char-
acterized microbes are shown in Table 1. The ratio of
bacteria was the highest at 63.48–89.65% of total valid reads
per sample. The ratio of fungi, protozoa and viruses were
between 2.14–14.34%, 3.57–31.71% and 0.13–0.53%, respec-
tively.
Sequence analysis of all identiﬁed viral reads was per-
formed to characterize any additional sequences. As shown
in Table 1, a BLAST search indicated that 44 (sample 1), 32
(sample 2) and 102 (sample 3) reads of the three samples
were novel A (H1N1)-derived, strongly indicating that these
patients were similarly infected with novel A (H1N1) virus,
consistent with previous RT-PCR diagnostic results (Gene-
bank accession number: GQ183617–GQ183624) [6]. Simi-
larly, 254 reads of sample 4 were derived from seasonal A
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(H3N2) virus according to BLAST searches. Inﬂuenza virus was
not detected in the control sample (sample 5). In addition,
several common human virus–derived sequences, including
adenovirus and herpesvirus were detected in all samples [7].
Maybe as a result of the addition of M-MLV reverse trans-
criptase during samples preparation, sequences correspond-
ing to murine leukaemia virus were detected.
Nucleic acid sequence-based methods have been used
extensively for the diagnosis of viral infection in recent years.
However, most methods depend on prior knowledge of
pathogen sequences, rendering them ineffective for detecting
unexpected or mutated viral sequences. This limitation may
be overcome by the use of new high-throughput sequencing
strategies. In the present study, we demonstrate the poten-
tial of our unbiased pangenomic approach for identifying
pathogenic viruses directly without advance genetic informa-
tion. cDNAs, as templates for the Solexa platform, were pre-
pared by random primer using RNAs extracted from clinical
samples. The system produced >5.908 million reads per run
within 48 h and enabled us to obtain an almost complete
spectrum of nucleotide information from each sample,
including bacteria, fungi, protozoa and viruses. Upon further
analysis of identiﬁed viral reads, inﬂuenza sequences were
present in 32–254 of the 158 327–580 424 valid reads in
each sample (Table 1). Importantly, the coverage rates were
in the range 8.39–44.56%, which is sufﬁcient for viral subtype
identiﬁcation. Novel A (H1N1) and seasonal A (H3N2)
viruses were detected in the absence of prior genetic infor-
mation, consistent with the classical RT-PCR diagnostic
method. This suggests that this approach can contribute to
the detection of unexpected or mutated virus by direct com-
parison with mutant and wild-type viral sequences in the Ref-
Seq database. Likewise, pathogens eliciting similar symptoms
could be distinguished in a single sample through analysis of
unbiased high-throughput sequencing results, enabling the
accurate diagnosis of mixed infection.
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TABLE 1. Summary of microbe sequence analysis in swab samples
Sample number 1 2 3 4 5
Total reads 298 249 331 249 580 424 176 489 158 327
Fungi 42 779 (14.34%) 21 572 (6.51%) 58 245 (10.04%) 7655 (4.34%) 3396 (2.14%)
Bacteria 239 804 (80.41%) 296 948 (89.65%) 485 943 (83.72%) 112 037 (63.48%) 131 617 (83.13%)
Protozoa 14 733 (4.94%) 11 820 (3.57%) 35 489 (6.11%) 55 970 (31.71%) 22 476 (14.20%)
Virus 933 (0.31%) 909 (0.27%) 747 (0.13%) 827 (0.47%) 838 (0.53%)
Inﬂuenza A viruses 44 32 102 254 0
Novel A (H1N1) 44 32 102 0 0
Seasonal A (H3N2) 0 0 0 254 0
Adenovirus 130 162 57 55 80
Herpesvirus 34 32 53 23 18
Murine leukaemia virus 32 28 23 37 36
Mapping to inﬂuenza A virus
Genome cover rate (%)
10.39 8.39 17.79 44.56 0
FIG. 1. Summary of sequencing reads using the Solexa system. Valid reads were used for BLASTN search analyses after removing duplicate reads
and reads with unrecognized sites or sequencing adaptors.
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Abstract
Group C rotavirus (GpC RV) causes sporadic cases and out-
breaks of acute diarrhoea in humans worldwide, but has not been
detected among children in South Korea. The present study
aimed to detect GpC RV among children hospitalized with gastro-
enteritis in South Korea and to perform a molecular characteriza-
tion of GpC RV strains. From November 2003 to January 2006,
434 faecal samples were collected from children <10 years of age
who were hospitalized for treatment of acute diarrhoea and
screened for group C and A rotaviruses by enzyme immunoassay.
GpC RV strains were characterized by sequence and phylogenetic
analysis.Of the 434 samples screened, two were positive for GpC
RV and one had a mixed GpC and GpA RV infection. One of the
strains, Icheon, shared high sequence conservation in VP4, VP6
and VP7 genes with other published GpC RV. This is the
ﬁrst report describing the molecular characteristics of GpC RV
among children in South Korea. Additional surveillance is needed
to determine the burden of GpC RV gastroenteritis.
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Rotaviruses are the most important cause of acute gastroen-
teritis in humans and a variety of animals [1]. Rotaviruses
possess a segmented, double-stranded RNA genome and are
classiﬁed into seven groups (A–G) based on their distinct-
ness with respect to genes and capsid proteins. Group A, B
and C rotaviruses cause disease in both humans and animals
[1]. Group C rotavirus (GpC RV), ﬁrst detected in piglets
[2] and an infant [3], has been associated with sporadic cases
and outbreaks of gastroenteritis among children and adults in
many countries [4–9]. GpC RV is generally considered to
cause a relatively milder disease, with fewer episodes of
vomiting per day and less dehydration compared to group A
rotavirus (GpA RV) infection in children [4,7].
All human GpC RV strains detected to date throughout
the world have shown high sequence conservation and
belong to single G and P genotypes [10,11]. By contrast,
human GpC strains are divergent from those in cattle and
swine [11–14]. In the present study, for the ﬁrst time, we
detected GpC RV in faecal samples from children with acute
diarrhoea in South Korea and determined the genetic relat-
edness of the Korean isolate to other published strains.
A total of 434 stool samples was collected from patients
<10 years of age, who were hospitalized for treatment of
gastroenteritis at Sungmo Hospital, Icheon, South Korea,
from November 2003 to January 2006. All 434 samples were
screened for GpA RV by using a Rotatek kit (South Korea
Green Cross Corp., Seoul, South Korea) [15] and, for GpC
RV, by using an in-house immunoassay developed with hyper-
immune sera against porcine GpC RV Cowden strain and
human GpC RV VLPs [4,16]. Brieﬂy, 96-well plates were
coated with porcine anti-GpC serum (U340; dilution 1:2000)
or normal porcine serum (Z1329; dilution 1:2000) in coating
buffer (35 mM NaHCO3, 15 mM Na2CO3, pH 9.6) and incu-
bated overnight at 4C. Plates were washed with phosphate
buffered saline-Tris (pH 7.6) and incubated with blotto for
1 h at 37C. Plates were washed and then incubated with
diluted stool samples (dilution 1:10) or GpC VLPs (positive
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